Table 2. The IC50 values of LH3 and MnIII complex treatment against breast cancer cell lines after 24 h treatment.
Compound/Drug | Cell line | IC50(µg/mL) |
---|---|---|
MnIIIcomplex | MCF-7 | 1.44 ± 0.24 |
MDA-MB-231 | 2.28 ± 0.38 | |
LH3 | MCF-7 | 3.51 ± 0.14 |
MDA-MB-231 | 2.41 ± 0.29 | |
Doxorubicin | MCF-7 | 2.55 ± 0.27 |
MDA-MB-231 | 1.84 ± 0.4 | |
Cisplatin | MCF-7 | 8.94 ± 0.66 |
MDA-MB-231 | 6.79 ± 1.22 | |
Tamoxifen | MCF-7 | 9.05 ± 0.19 |
MDA-MB-231 | 10.48 ± 0.45 |
Notes.
Cisplatin, doxorubicin, and tamoxifen were used as positive controls.